ASTH
Astrana Health Shines in Q3 2026: Strong Revenue Growth, Record Adjusted EBITDA, and Robust Free Cash Flow
Astrana Health's third quarter of 2026 was marked by outstanding performance, with the company delivering a record-breaking $1.02 billion in revenue, up 7% year-over-year. This impressive growth was driven by continued expansion in margin, as well as disciplined execution across the business. The adjusted EBITDA (Earnings Before